Antibiogram compliance in University HealthSystem Consortium participating hospitals with Clinical and Laboratory Standards Institute guidelines

American Journal of Health-System Pharmacy

Volumn 69, Issue 7, 2012, Pages 598-606

  Xu, Ran ^a   Polk, Ronald E ^b   Stencel, Lynda ^c   Lowe, Denise K ^d,e,f   Guha, Roy ^g   Duggal, Raj W ^h   Wiest, Michelle ^h   Putney, Kimberly S ^i,j   Flint, Nora B ^k  

^a St Luke's the Woodlands Hospital   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c University HealthSystem Consortium ^*  (United States)

^d Drug Information Services   (United States)

^e VCU Health System   (United States)

^f U of WI School of Pharmacy   (United States)

^g UMASS MEMORIAL MEDICAL CENTER   (United States)

^h UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

ⁱ Emergency Services   (United States)

^j St Luke's Episcopal Hospital   (United States)

^k RUSH UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Administration; Antiinfective agents; Compliance; Data collection; Hospitals; Minimum inhibitory concentration; Pharmacists, hospital; Pharmacy, institutional, hospital; Protocols

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL LABORATORY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HOSPITAL POLICY; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION; UNIVERSITY HOSPITAL;

EID: 84858989031     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110332     Document Type: Article

References (17)

1. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline. 3rd ed. CLSI document M39-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
2. Critchley IA, Karlowsky JA. Optimal use of antibiotic resistance surveillance systems. Clin Microbiol Infect. 2004; 10:502-11. (Pubitemid 38961574)
3. Ginocchio CC. Role of NCCLS in antimicrobial susceptibility testing and monitoring. Am J Health-Syst Pharm. 2002; 59(suppl 3):S7-11.
4. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline. NCCLS document M39-A. Wayne, PA: National Committee on Clinical Laboratory Standards; 2002.
5. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute; 2010 Jan.
6. Fridkin SK, Edwards JR, Tenover FC et al. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis. 2001; 33:324-30.
7. Beardsley JR, Williamson JC, Johnson JW et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. 2006; 130:787-93. (Pubitemid 44423610)
8. Ernst EJ, Diekema DJ, BootsMiller BJ et al. Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? Diagn Microbiol Infect Dis. 2004; 49:141-5. (Pubitemid 38746744)
9. Zapantis A, Lacy MK, Horvat RT et al. Nationwide antibiogram analysis using NCCLS M39-A guidelines. J Clin Microbiol. 2005; 43:2629-34. (Pubitemid 40827932)
10. Lautenbach E, Nachamkin I. Analysis and presentation of cumulative antimicrobial susceptibility data (antibiograms): substantial variability across medical centers in the United States. Infect Control Hosp Epidemiol. 2006; 27:409-12. (Pubitemid 43736108)
11. Kaufman D, Haas CE, Edinger R et al. Antibiotic susceptibility in the surgical intensive care unit compared with the hospital-wide antibiogram. Arch Surg. 1998; 133:1041-5. (Pubitemid 28480464)
12. Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother. 2008; 61:436-41.
13. Harbarth S, Garbino J, Pugin J et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003; 115:529-35. (Pubitemid 37352798)
14. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003; 31:2742-51. (Pubitemid 38010630)
15. Ibrahim EH, Sherman G, Ward S et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000; 118:146-55. (Pubitemid 30485502)
16. Leibovici L, Shraga I, Drucker M et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998; 244:379-86. (Pubitemid 28513125)
17. Draugalis JR, Coons SJ, Plaza CM. Best practices for survey research reports: a synopsis for authors and reviewers. Am J Pharm Educ. 2008; 72:11.